Blog

Cell and Gene Therapy Series. Part 4 | 3P Innovation

Written by Dr. Dave Seaward | 28 February 2022

As we continue to explore the world of cell and gene therapy, we now take a look at managing costs and scale up risks for medical devices.

Author Dave Seward, discusses how the principles of Quality by Design (QbD) and Design for Manufacture (DfM) can be applicable to ATMPs. Read this blog now!